Hempyreum.org
Local Time
English (UK) Deutsch (DE) Français (FR) Español (ES) Italian (IT)
Canntab Therapeutics Signs Joint Venture Agreement with Queensland Bauxite Subsidiary
Author: Alison Cameron 10/01/2018 - 16:43:00

Canntab Therapeutics has recently entered into a joint venture agreement with VitaCann, a subsidiary of Medical Cannabis, which is owned by Queensland Bauxite (ASX:QBL) in Australia. The Finance News Network published a video segment regarding the news, highlighting that the companies are working towards having Canntab tablets approved for sale within the Australian market and for export to Asia. 

This joint venture has positioned Canntab and its Australian partner favorably to expand production and manufacturing of the Medical Cannabis seed bank and products within the Australian market. 

To watch the full video segment, click here

Click here to connect with Canntab Therapeutics for investor information 

The post Canntab Therapeutics Signs Joint Venture Agreement with Queensland Bauxite Subsidiary appeared first on Investing News Network

Original article from investingnews.com: Canntab Therapeutics Signs Joint Venture Agreement with Queensland Bauxite Subsidiary



info
Total pages / language:   27'491 / 17'019
In the archive :   46'558
Pages last 24 hours:   33
This Month Pages:   680
Views:   6'660'1964'334
Views Archive:   10'197'648

©2018 - Hempyreum.org - News aggregator about Hemp and Cannabis [Beta] | All rights and ownership of the contents belong to their respective holders

Advertising